1. Home
  2. Advocacy
  3. Latest News and Practice Data
  4. Common Questions Answered About the CAP’s Amicus Brief on LDTs

Common Questions Answered About the CAP’s Amicus Brief on LDTs

Oct 15, 2024

Our laboratory-developed test (LDT) oversight FAQ webpage now includes commonly asked and answered questions about the CAP’s amicus brief court filing from October 7.

In the amicus brief, the CAP urged a US Federal District Court to vacate the FDA regulation for several reasons, including the ultimate impact on patient access to these critically important diagnostic tests and the FDA failing to adequately justify the rule’s unsustainable costs that will hinder the development of LDTs.

Most Recent Content

  1. What pathologists are telling their lawmakers before New Year's Eve
    Advocacy Updates Advocacy Updates
    Dec 3, 2025
  2. Protecting patient access to diagnostic testing across the US
    Advocacy Updates Advocacy Updates
    Dec 3, 2025
  3. Prepare for 2026 payment changes
    Advocacy Updates Advocacy Updates
    Dec 3, 2025
  4. Coming soon… "Case Encounters"
    Advocacy Updates Advocacy Updates
    Dec 3, 2025
  5. November CAP media highlights
    Advocacy Updates Advocacy Updates
    Dec 3, 2025
  6. View All
To Top